Study shows promise for Medtronic's insulin pump

06/25/2013 | (Boston)

Nocturnal hypoglycemia and type 1 diabetes patients who used Medtronic's MiniMed insulin pump were 31.8% less likely to experience acute events, according to a study in the New England Journal of Medicine. The device, which features a program that changes insulin delivery when glucose readings reach predetermined levels, is said to be the first step toward the creation of a fully automated artificial pancreas.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX